HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality

HIV Medicine, 05/30/2012

Authors observed excessive morbidity and mortality in this HIV/HCV–coinfected population in care. Over 50% of observed deaths may have been preventable. Interventions aimed at improving social circumstances, reducing harm from drug and alcohol use and increasing the delivery of HCV treatment in particular will be necessary to reduce adverse health outcomes among HIV/HCV–coinfected persons.

Print Article Summary Cat 2 CME Report